Drug
Buntanetap Posiphen
Buntanetap Posiphen: highest development phase Phase 2/3, developed by Annovis Bio Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Annovis Bio Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| buntanetap/posiphen NCT07757204 | Phase 2/3 | Alzheimer's Dementia (AD) |
Latest
No recent events.
Follow Buntanetap Posiphen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.